By integrating our research results with previous findings18, we surmised that the mevalonate pathway might play an important role in maintaining the normal function of human epidermis, and inhibition of the mevalonate metabolism might be a driver of MVK- and PMVK-associated porokeratosis. Here, MVK is linked to porokeratosis.